Polysaccharides isolated from Hedyotis diffusa inhibits the aggressive phenotypes of laryngeal squamous carcinoma cells via inhibition of Bcl-2, MMP-2, and μPA

Gene. 2017 Dec 30:637:124-129. doi: 10.1016/j.gene.2017.09.041. Epub 2017 Sep 21.

Abstract

Hedyotis diffusa, a traditional Chinese herbal medicine, possesses anti-cancer, anti-oxidative, and anti-inflammatory effects. The aim of this study is to explore the anti-tumor potential of Hedyotis diffusa polysaccharides (HDP) in human larynx squamous carcinoma. High performance size-exclusion chromatography analysis indicated the homogeneous nature of HDP. Total carbohydrate content in HDP was 97.3%, without contamination of protein and nucleic acid. HDP suppressed the proliferation of Hep2 human larynx squamous carcinoma cells in a time- and dose-dependent manner. Cell cycle analysis revealed that exposure to HDP (400μg/ml) caused a G0/G1 cell cycle arrest. Moreover, treatment with HDP for 24h induced a significant apoptosis of Hep2 cells, which was accompanied by increased cleavage of caspase-3, caspase-8, and caspase-9 and reduced expression of Bcl-2 protein. Additionally, HDP inhibited cell migration and suppressed the expression of MMP-2 and μPA. In conclusion, HDP shows suppressive effects against the aggressive phenotypes of human larynx squamous carcinoma cells and may have therapeutic potential for this malignancy.

Keywords: Hedyotis diffusa; Migration; Polysaccharides; Squamous cell carcinoma.

MeSH terms

  • Apoptosis / drug effects
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / metabolism
  • Carcinoma, Squamous Cell / pathology
  • Cell Proliferation / drug effects
  • G1 Phase Cell Cycle Checkpoints / drug effects
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Hedyotis / chemistry
  • Humans
  • Laryngeal Neoplasms / drug therapy*
  • Laryngeal Neoplasms / metabolism
  • Laryngeal Neoplasms / pathology
  • Matrix Metalloproteinase 2 / chemistry*
  • Matrix Metalloproteinase 2 / metabolism
  • Phenotype
  • Plant Extracts / pharmacology
  • Polysaccharides / pharmacology*
  • Proto-Oncogene Proteins c-bcl-2 / antagonists & inhibitors*
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Tumor Cells, Cultured
  • Urokinase-Type Plasminogen Activator / antagonists & inhibitors*
  • Urokinase-Type Plasminogen Activator / metabolism

Substances

  • Plant Extracts
  • Polysaccharides
  • Proto-Oncogene Proteins c-bcl-2
  • Urokinase-Type Plasminogen Activator
  • MMP2 protein, human
  • Matrix Metalloproteinase 2